Scientific Papers

Scientific papers are separated by the original language of publication. To access the scientific papers select the desired language at the top of the page.

  1. Fully Automated System for PKU/GAL/MSUD/BIO using 384 Well Microplates.(2016)
  2. Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A‑202A/376G variant. (2016)
  3. Continuous Improvement in the Newborn Screening Program of the State of Rio de Janeiro, Brazil.(2015)
  4. The use of Percentiles for Determination of Cut-off Values in Newborn Screening Using Totally Automated System and Multiplex Assays.(2015)
  5. Evaluation Of Neolisa® MSUD Kit in Maple Syrup Urine Disease Child Monitoring in a Reference Service for Newborn Screening.(2015)
  6. A Totally Automated System for Newborn Screening of PKU, GAL and MSUD using 384 well microplates.(2015)
  7. Newborn Screening for Biotinidase Deficiency Using a Totally Automated System and Enzymatic Analysis With Results Expressed in nmol/min/mL.(2015)
  8. Relationship Between Anthropometric Development and Metabolic Control of Children With Diagnosis of Maple Syrup Urine Disease (MSUD) Monitored in a Reference Service in Newborn Screening (RSNS).(2015)
  9. Multiplex analysis using a totally automated system for Newborn Screening of Congenital Hypothyroidism, Congenital Adrenal Hyperplasia and Cystic Fibrosis in the Northeast of Brazil.(2015)
  10. Clinical and Laboratory Characterization of Patients With Maple Syrup Urine Disease Followed in a Reference Service for Newborn Screening in Salvador, Bahia, Brazil.(2015)
  11. Results Obtained From the Use of a New Fully Automated System for Newborn Screening, Using Intercientifica Products.(2013)
  12. NeoLISA PKU Product Performance in a Fully Automated System.(2013)
  13. Development of Fully Automated Multiplex Assay for Measurement of Thyroid-stimulating hormone, T4, 17-OHP, and IRT.(2013)
  14. Evaluation of effectiveness and outcome of PKU screening and management in the State of Sergipe, Brazil.(2013)
  15. Glucose-6-phosphate-dehydrogenase deficiency and its correlation with other risk factors in jaundiced newborns in Southern Brazil.(2011)
  16. Preliminare multicentre study for Infectious Diseases evaluating a new product for Neonatal Screening and Prenatal screening using DBS samples in different regions of Brazil.(2009) 
  17. Prevalence of G6PD deficiency in newborns in the south of Brazil.(2006)
  18. Comparative study between two different methods for quantification of TSH in Newborn Screening.(2005)
  19. Hemoglobin Normalization Procedure for Precise Analyse of G6PD Activity in Newborn Screening.(2005)
  20. The simultaneous detection of antibodies for ToRCH NeoMAP INTERSCIENTIFIC Kit.(2005)
  21. A New Confirmatory Assay for Cystic Fibrosis using a multiplex assay.(2005)
  22. Testing for G6PD Deficiency: Clinical and laboratory aspects.(2005)
  23. The use of NeoMAP Technology in Newborn Screening for Congenital Hypotyroidism.(2003)
  24. The experience of APAE-Anápolis using a completely automated protocol in Newborn Screening for Phenylketonuria (PKU).(2003)
  25. A New method for the simultaneous quantification of TSH and T4 in Newborn Screening for Congenital Hypothyroidism.(2003)
  26. Utilization of a normal “zero” standard leads to better reproducibility and discrimination at the low end values in PKU screening.(2002)
  27. A new colorimetric kit for PKU screening with higher signal and better slope.(2002)
  28. Hemoglobin normalization leads to correct classification of samples derived from wrong blood spots (2002)
  29. A new rapid assay using our “Hemoglobin Normalization” method for the determination of G6PD activity in neonates (2002)